35H Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Homology Medicines Inc - Alpha Spread

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 14.85 EUR Market Closed

Market Cap: €4.1B

Profitability Summary

Homology Medicines Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

Negative 3Y Average Operating Margin

Operating Margin is Increasing

Exceptional Net Margin

Negative 3Y Average Net Margin

Net Margin is Increasing

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Exceptional ROE

Exceptional 3Y Average ROE

ROE is Increasing

Exceptional ROIC

Negative 3Y Average ROIC

ROIC is Increasing

View All Checks

Sign In

Sign Up

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

Negative 3Y Average Operating Margin

Operating Margin is Increasing

Exceptional Net Margin

Negative 3Y Average Net Margin

Net Margin is Increasing

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Exceptional ROE

Exceptional 3Y Average ROE

ROE is Increasing

Exceptional ROIC

Negative 3Y Average ROIC

ROIC is Increasing

View All

View All

Hide

Collapse

Sign In

Sign Up

Margins

Return on Capital

Free Cash Flow

See Also

Relative Valuation

Wall St Estimates

Back to Top

Join 342,900+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Get AI-powered insights for any company or topic.

Open AI Assistant

Stock Screener

Discover stocks

Stock Comparison

Smarter decisions through side-by-side analysis

Intrinsic Value Calculator

Discover the true worth of your stocks

DCF Value Calculator

Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.